BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20417496)

  • 1. Maternal use of bupropion and risk for congenital heart defects.
    Alwan S; Reefhuis J; Botto LD; Rasmussen SA; Correa A; Friedman JM;
    Am J Obstet Gynecol; 2010 Jul; 203(1):52.e1-6. PubMed ID: 20417496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bupropion in pregnancy and the prevalence of congenital malformations.
    Cole JA; Modell JG; Haight BR; Cosmatos IS; Stoler JM; Walker AM
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):474-84. PubMed ID: 16897811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-trimester exposure to bupropion and risk of cardiac malformations.
    Louik C; Kerr S; Mitchell AA
    Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1066-75. PubMed ID: 24920293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion (amfebutamone): caution during pregnancy.
    Prescrire Int; 2005 Dec; 14(80):225. PubMed ID: 16400747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal smoking and congenital heart defects.
    Malik S; Cleves MA; Honein MA; Romitti PA; Botto LD; Yang S; Hobbs CA;
    Pediatrics; 2008 Apr; 121(4):e810-6. PubMed ID: 18381510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bupropion: congenital heart defects (continued).
    Prescrire Int; 2012 Apr; 21(126):97. PubMed ID: 22515134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proximity of residence to trichloroethylene-emitting sites and increased risk of offspring congenital heart defects among older women.
    Yauck JS; Malloy ME; Blair K; Simpson PM; McCarver DG
    Birth Defects Res A Clin Mol Teratol; 2004 Oct; 70(10):808-14. PubMed ID: 15390315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.
    Einarson A; Pistelli A; DeSantis M; Malm H; Paulus WD; Panchaud A; Kennedy D; Einarson TR; Koren G
    Am J Psychiatry; 2008 Jun; 165(6):749-52. PubMed ID: 18381907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies.
    Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS
    Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental pathologic conditions in anticardiolipin antibody positive women whose infants had congenital heart defects.
    Kowal-Vern A; Fisher SG; Muraskas J; Jandreski MA; Gianopoulos JG; Husain A
    J Perinatol; 1996; 16(4):268-71. PubMed ID: 8866295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects.
    Cleves MA; Savell VH; Raj S; Zhao W; Correa A; Werler MM; Hobbs CA;
    Birth Defects Res A Clin Mol Teratol; 2004 Mar; 70(3):107-13. PubMed ID: 15039924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between congenital heart defects and small for gestational age.
    Malik S; Cleves MA; Zhao W; Correa A; Hobbs CA;
    Pediatrics; 2007 Apr; 119(4):e976-82. PubMed ID: 17387169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants.
    Loffredo CA; Wilson PD; Ferencz C
    Teratology; 2001 Aug; 64(2):98-106. PubMed ID: 11460261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study.
    Botto LD; Khoury MJ; Mulinare J; Erickson JD
    Pediatrics; 1996 Nov; 98(5):911-7. PubMed ID: 8909485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prepregnancy body mass index and congenital heart defects among offspring: a population-based study.
    Madsen NL; Schwartz SM; Lewin MB; Mueller BA
    Congenit Heart Dis; 2013; 8(2):131-41. PubMed ID: 22967199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal febrile illnesses, medication use, and the risk of congenital renal anomalies.
    Abe K; Honein MA; Moore CA
    Birth Defects Res A Clin Mol Teratol; 2003 Nov; 67(11):911-8. PubMed ID: 14745928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital syphilis: identification of two distinct profiles of maternal characteristics associated with risk.
    Lago EG; Rodrigues LC; Fiori RM; Stein AT
    Sex Transm Dis; 2004 Jan; 31(1):33-7. PubMed ID: 14695956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal residential proximity to waste sites and industrial facilities and conotruncal heart defects in offspring.
    Langlois PH; Brender JD; Suarez L; Zhan FB; Mistry JH; Scheuerle A; Moody K
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):321-31. PubMed ID: 19523079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal periconceptional illicit drug use and the risk of congenital malformations.
    van Gelder MM; Reefhuis J; Caton AR; Werler MM; Druschel CM; Roeleveld N;
    Epidemiology; 2009 Jan; 20(1):60-6. PubMed ID: 19057385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposures and congenital heart defects in Down syndrome infants.
    Fixler DE; Threlkeld N
    Teratology; 1998 Jul; 58(1):6-12. PubMed ID: 9699239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.